BrainGate™ is a transformative neurotechnology owned and operated by Tufts University that uses micro-electrodes implanted in the brain to let humans operate external devices such as computers or robotic arms with just their thought.
Through years of advanced research, BrainGate™ is at the forefront of enabling severely motor-impaired individuals with the ability to communicate, interact, and function through thought.
The Stibel Dennett Consortium at Tufts is a cognitive research hub to further build upon the BrainGate™ technology and other advances in brain and cognitive sciences. BrainGate™ is a foundational platform for BCI technologies being developed around the world, and Tufts now controls all permissions and rights to its use or commercialization by other organizations.
Access to the cutting-edge technology of BrainGate™ opens up incredible opportunities for engaging in new lines of research, building partnerships with other institutions in this space, and for exploring how Tufts might leverage this technology through private or public partnerships.